Threshold Pharmaceuticals (THLD), returns to earth following a big burst higher at the open. The...

|By:, SA News Editor

Threshold Pharmaceuticals (THLD), returns to earth following a big burst higher at the open. The stock jumped on the drug developers announcement that U.S. regulators have reached an agreement covering a special protocol assessment for Phase III trials of it's TH-302 drug candidate, a treatment for patients with metastatic pancreatic cancer.